25 January 2012 - German generic drugs specialist Stada (ETR:SAZ) intends to pay dividends totalling between 30% and 35% of its net profit for 2011 to shareholders, Frankfurter Allgemeine Sonntagszeitung reported citing CFO Helmut Kraft.

For 2010 Stada paid a dividend of EUR0.37 (USD0.48) per share.

The performance, however, was affected by a loss of accounts receivable from the firm's operations in Serbia, due to which the net profit for the third quarter of 2011 was burdened by EUR87m.

Despite the economic headwinds and the problems in Serbia, Stada expects to have achieved its financial targets for 2011.

Furthermore, Stada is considering whether to hike its long-term outlook for growth in earnings before interest, tax, depreciation and amortisation (EBITDA). In 2011 EBITDA was expected to grow at a rate in the higher single-digit percentage range.

(EUR1 = USD1.302)